Other Key Updates and Ongoing Research in Non-Advanced Systemic Mastocytosis From ASH 2025

Lindsay Rein, MD, and Frederick Lansigan, MD, highlight other notable data in non-advanced systemic mastocytosis presented at the 2025 ASH Annual Meeting and Exposition. They discuss emerging therapies, ongoing clinical trials, and areas of active investigation aimed at improving symptom control and quality of life. Rein and Lansigan conclude by emphasizing future research directions and closing the program with final reflections on progress in the field.